Offshoring Clinical Trials (The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel.)

Table of Contents

Chapter One: Executive Summary

• Introduction
• Scope and Methodology
• Size and Growth of the Market
• Issues and Trends Affecting Market
• Company Profiles

Chapter Two: Introduction

• Clinical Trials Overview
• Regulatory Environment
• Overview
• Demographics and Statistics
• Worldwide Demographics
• Incidence, Prevalence of Disease

Chapter Three: Clinical Trials in India

• Overview
• Country Demographics
• Clinical Trials Analysis in India
• Mumbai
• Delhi
• Kolkatta (formerly Calcutta)
• Bangalore
• Issues and Trends
• Literacy Rates
• Regulatory Environment and Government Support
• Market Analysis
• Market Drivers and Inhibitors
• Market Size and Growth
• Company Profiles
• Accutest Research Laboratories Pvt. Ltd.
• ClinInvent Research Pvt. Ltd.
• SIRO Clinpharm Pvt. Ltd.
• Manipal Acunova Ltd.

Chapter Four: Clinical Trials in Russia

• Overview
• Country Demographics
• Clinical Trials Analysis in Russia
• Moscow
• St. Petersburg
• Novosibirsk
• Nizhniy Novgorod
• Issues and Trends
• Regulatory Environment and Government Support
• Government Restrictions
• Market Analysis
• Market Drivers and Inhibitors
• Market Size and Growth
• Company Profiles
• Accell Clinical Research, LLC
• Congenix
• Hesperion Russia
• InnoPharm Ltd.

Chapter Five: Clinical Trials in China

• Overview
• Country Demographics
• Clinical Trials Analysis in China
• Shanghai
• Beijing
• Hong Kong
• Tianjin
• Issues and Trends
• Regulatory Environment and Government Support
• Market Analysis
• Market Drivers and Inhibitors
• Market Size and Growth
• Company Profiles
• GleneaglesCRC Pte Ltd
• PHDS Healthcare Research
• Quintiles Asia, Inc.

Chapter Six: Clinical Trials in Brazil

• Overview
• Country Demographics
• Clinical Trials Analysis in Brazil
• Sao Paulo
• Belo Horizonte
• Rio de Janeiro
• Salvador
• Issues and Trends
• Regulatory Environment and Government Support
• Market Analysis
• Market Drivers and Inhibitors
• Market Size and Growth
• Company Profiles
• ProMedica Clinical Research LLC
• AAIPharma, Inc.

Chapter Seven: Clinical Trials in Mexico

• Overview
• Country Demographics
• Clinical Trials Analysis in Mexico
• Mexico City
• Guadalajara
• Puebla
• Tijuana
• Issues and Trends
• Market Analysis
• Market Drivers and Inhibitors
• Market Size and Growth
• Company Profiles
• Mmatiss
• Kendle

Chapter Eight: Clinical Trials in Israel

• Overview
• Country Demographics
• Clinical Trials Analysis in Israel
• Jerusalem
• Tel Aviv
• Haifa
• Rishon Lezion
• Issues and Trends
• Regulatory Environment and Government Support
• Market Analysis
• Market Drivers and Inhibitors
• Market Size and Growth
• Company Profiles
• Cato Research Israel
• Criterium, Inc.
• PharmaSeed Ltd.

Chapter One: Executive Summary

• Table 1-1: Clinical Trial Market in Select Country 2006-2012
• Figure 1-1: Clinical Trial Market in Select Country 2006 and 2012
• Figure 1-2: Clinical Trial Market - Six Developing Markets vs. United States and Rest of World Markets, 2006
• Table 1-2: Clinical Trials in Six Developing Markets by Disease/Condition
• Figure 1-3: Clinical Trials in Six Developing Markets by Disease/Condition

Chapter Two: Introduction

• Table 2-1: Clinical Trial Overview
• Table 2-2: Registered Clinical Trials by Select Country
• Figure 2-1: Registered Clinical Trials by Select Country
• Table 2-3: Regulatory Agencies by Country
• Table 2-4: World Population by Selected Geographical Region, 2006-2050
• Figure 2-2: World Population by Selected Geographical Region, 2006-2050
• Table 2-5: Estimated World Population by Age and Geographical Region, 2006
• Figure 2-3: Estimated World Population by Age and Geographical Region, 2006
• Table 2-6: Worldwide and United States Incidence/Prevalence of Disease or Condition, Estimated 2006

Chapter Three: Clinical Trials in India

• Table 3-1: India - Midyear Population, by Age and Sex
• Figure 3-1: India - Midyear Population, by Age
• Table 3-2: Registered Clinical Trials in India by Metro Area
• Figure 3-2: Registered Clinical Trials in India by Metro Area
• Table 3-3: Registered Clinical Trials in India by Disease, Condition, and/or Specialty
• Figure 3-3: Registered Clinical Trials in India by Disease, Condition, and/or Specialty
• Table 3-4: Clinical Trials in Mumbai, India by Disease/Condition
• Figure 3-5: Clinical Trials in Mumbai, India - Distribution by Disease/Condition
• Figure 3-6: Clinical Trials in Mumbai, India by Disease/Condition
• Table 3-5: Clinical Trials in Delhi, India by Disease/Condition
• Figure 3-7: Clinical Trials in Delhi, India - Distribution by Disease/Condition
• Figure 3-8: Clinical Trials in Delhi, India by Disease/Condition
• Table 3-6: Clinical Trials in Kolkata (Calcutta), India by Disease/Condition
• Figure 3-9: Clinical Trials in Kolkata (Calcutta), India by Disease/Condition
• Table 3-7: Clinical Trials in Bangalore, India by Disease/Condition
• Figure 3-10: Clinical Trials in Bangalore, India - Distribution by Disease/Condition
• Figure 3-11: Clinical Trials in Bangalore, India by Disease/Condition
• Table 3-8: Number of Literates and Literacy Rate, India
• Table 3-9: Comparison of Clinical Trail Market Drivers and Inhibitors - India
• Table 3-10: Clinical Trial Market in India 2006-2012
• Figure 3-12: Clinical Trial Market in India 2006-2012
• Figure 3-13: Clinical Trial Market - India vs. World Markets, 2006

Chapter Four: Clinical Trials in Russia

• Table 4-1: Russia - Midyear Population, by Age and Sex
• Figure 4-1: Russia - Midyear Population, by Age
• Table 4-2: Registered Clinical Trials in Russia by Metro Area
• Figure 4-2: Registered Clinical Trials in Russia by Metro Area
• Table 4-3: Registered Clinical Trials in Russia by Disease, Condition, and/or Specialty
• Figure 4-3: Registered Clinical Trials in Russia by Disease, Condition, and/or Specialty
• Table 4-4: Clinical Trials in Moscow, Russia by Disease/Condition
• Figure 4-4: Clinical Trials in Moscow, Russia - Distribution by Disease/Condition
• Figure 4-5: Clinical Trials in Moscow, Russia by Disease/Condition
• Table 4-5: Clinical Trials in St. Petersburg, Russia by Disease/Condition
• Figure 4-6: Clinical Trials in St. Petersburg, Russia - Distribution by Disease/Condition
• Figure 4-7: Clinical Trials in St. Petersburg, Russia by Disease/Condition
• Table 4-6: Clinical Trials in Novosibirsk, Russia by Disease/Condition
• Figure 4-8: Clinical Trials in Novosibirsk, Russia - Distribution by Disease/Condition
• Figure 4-9: Clinical Trials in Novosibirsk, Russia by Disease/Condition
• Table 4-7: Clinical Trials in Nizhniy Novgorod, Russia by Disease/Condition
• Figure 4-10: Clinical Trials in Nizhniy Novgorod, Russia - Distribution by Disease/Condition
• Figure 4-11: Clinical Trials in Nizhniy Novgorod, Russia by Disease/Condition
• Table 4-8: Comparison of Clinical Trail Market Drivers and Inhibitors - Russia
• Table 4-9: Clinical Trial Market in Russia 2006-2012 Compound Annual Growth Rate
• Figure 4-12: Clinical Trial Market in Russia 2006-2012
• Figure 4-13: Clinical Trial Market - Russia vs. World Markets, 2006

Chapter Five: Clinical Trials in China

• Table 5-1: China - Midyear Population, by Age and Sex
• Figure 5-1: China - Midyear Population, by Age, 2006 and 2012
• Table 5-2: Registered Clinical Trials in China by Metro Area
• Figure 5-2: Registered Clinical Trials in China by Metro Area
• Table 5-3: Registered Clinical Trials in China by Disease, Condition, and/or Specialty
• Figure 5-3: Registered Clinical Trials in China by Disease, Condition, and/or Specialty
• Table 5-4: Clinical Trials in Shanghai, China by Disease/Condition
• Figure 5-4: Clinical Trials in Shanghai, China Distributionby Disease/Condition
• Figure 5-5: Clinical Trials in Shanghai, China by Disease/Condition
• Table 5-5: Clinical Trials in Beijing, China by Disease/Condition
• Figure 5-6: Clinical Trials in Beijing, China - Distribution by Disease/Condition
• Figure 5-7: Clinical Trials in Beijing, China by Disease/Condition
• Table 5-6: Clinical Trials in Hong Kong, China by Disease/Condition Clinical Trials in Hong Kong, China - Distribution by Disease/Condition
• Figure 5-9: Clinical Trials in Hong Kong, China by Disease/Condition
• Table 5-7: Clinical Trials in Tianjin, China by Disease/Condition
• Figure 5-10: Clinical Trials in Tianjin, China - Distribution by Disease/Condition
• Figure 5-11: Clinical Trials in Tianjin, China by Disease/Condition
• Table 5-8: Comparison of Clinical Trail Market Drivers and Inhibitors - China
• Table 5-9: Clinical Trial Market in China 2006-2012
• Figure 5-12: Clinical Trial Market in China 2006-2012
• Figure 5-13: Clinical Trial Market - China vs. World Markets, 2006

Chapter Six: Clinical Trials in Brazil

• Table 6-1: Brazil - Midyear Population, by Age and Sex
• Figure 6-1: Brazil - Midyear Population, by Age and Sex, 2006 and 2012
• Table 6-2: Registered Clinical Trials in Brazil by Metro Area
• Figure 6-2: Registered Clinical Trials in Brazil by Metro Area
• Table 6-3: Registered Clinical Trials in Brazil by Disease, Condition, and/or Specialty
• Figure 6-3: Registered Clinical Trials in Brazil by Disease, Condition, and/or Specialty
• Table 6-4: Clinical Trials in Sao Paulo, Brazil by Disease/Condition
• Figure 6-4: Clinical Trials in Sao Paulo, Brazil - Distribution by Disease/Condition
• Figure 6-5: Clinical Trials in Sao Paulo, Brazil by Disease/Condition
• Table 6-5: Clinical Trials in Belo Horizonte, Brazil by Disease/Condition
• Figure 6-6: Clinical Trials in Belo Horizonte, Brazil - Distribution by Disease/Condition
• Figure 6-7: Clinical Trials in Belo Horizonte, Brazil by Disease/Condition
• Table 6-6: Clinical Trials in Rio de Janeiro, Brazil by Disease/Condition
• Figure 6-8: Clinical Trials in Rio de Janeiro, Brazil - Distribution by Disease/Condition
• Figure 6-9: Clinical Trials in Rio de Janeiro, Brazil by Disease/Condition
• Table 6-7: Clinical Trials in Salvador, Brazil by Disease/Condition
• Figure 6-10: Clinical Trials in Salvador, Brazil - Distribution by Disease/Condition
• Figure 6-11: Clinical Trials in Salvador, Brazil by Disease/Condition
• Table 6-8: Comparison of Clinical Trail Market Drivers and Inhibitors - Brazil
• Table 6-9: Clinical Trial Market in Brazil 2006-2012
• Figure 6-12: Clinical Trial Market in Brazil 2006-2012
• Figure 6-13: Clinical Trial Market - Brazil vs. World Markets, 2006

Chapter Seven: Clinical Trials in Mexico

• Table 7-1: Mexico - Midyear Population, by Age and Sex
• Figure 7-1: Mexico - Midyear Population, by Age and Sex
• Table 7-2: Registered Clinical Trials in Mexico by Metro Area
• Figure 7-2: Registered Clinical Trials in Mexico by Metro Area
• Table 7-3: Registered Clinical Trials in Mexico by Disease, Condition, and/or Specialty
• Figure 7-3: Registered Clinical Trials in Mexico by Disease, Condition, and/or Specialty
• Table 7-4: Clinical Trials in Mexico City, Mexico by Disease/Condition
• Figure 7-4: Clinical Trials in Mexico City, Mexico - Distribution by Disease/Condition
• Figure 7-5: Clinical Trials in Mexico City, Mexico by Disease/Condition
• Table 7-5: Clinical Trials in Guadalajara, Mexico by Disease/Condition
• Figure 7-6: Clinical Trials in Guadalajara, Mexico - Distribution by Disease/Condition
• Figure 7-7: Clinical Trials in Guadalajara, Mexico by Disease/Condition
• Table 7-6: Clinical Trials in Puebla, Mexico by Disease/Condition
• Figure 7-8: Clinical Trials in Puebla, Mexico - Distribution by Disease/Condition
• Figure 7-9: Clinical Trials in Puebla, Mexico by Disease/Condition
• Table 7-7: Clinical Trials in Tijuana, Mexico by Disease/Condition
• Figure 7-10: Clinical Trials in Tijuana, Mexico - Distribution by Disease/Condition.
• Figure 7-11: Clinical Trials in Tijuana, Mexico by Disease/Condition
• Table 7-8: Comparison of Clinical Trail Market Drivers and Inhibitors - Mexico
• Table 7-9: Clinical Trial Market in Mexico 2006-2012
• Figure 7-12: Clinical Trial Market in Mexico 2006-2012
• Figure 7-13: Clinical Trial Market - Mexico vs. World Markets, 2006

Chapter Eight: Clinical Trials in Israel

• Table 8-1: Israel - Midyear Population, by Age and Sex
• Figure 8-1: Israel - Midyear Population, by Age and Sex, 2006 and 2012
• Table 8-2: Registered Clinical Trials in Israel by Metro Area
• Figure 8-2: Registered Clinical Trials in Israel by Metro Area
• Table 8-3: Registered Clinical Trials in Israel by Disease, Condition, and/or Specialty
• Figure 8-3: Registered Clinical Trials in Israel by Disease, Condition, and/or Specialty
• Table 8-4: Clinical Trials in Jerusalem, Israel by Disease/Condition
• Figure 8-4: Clinical Trials in Jerusalem, Israel - Distribution by Disease/Condition..
• Figure 8-5: Clinical Trials in Jerusalem, Israel by Disease/Condition
• Table 8-5: Clinical Trials in Tel Aviv, Israel by Disease/Condition
• Clinical Trials in Tel Aviv, Israel - Distribution by Disease/Condition
• Figure 8-7: Clinical Trials in Tel Aviv, Israel by Disease/Condition
• Table 8-6: Clinical Trials in Haifa, Israel by Disease/Condition
• Figure 8-8: Clinical Trials in Haifa, Israel - Distribution by Disease/Condition
• Figure 8-9: Clinical Trials in Haifa, Israel by Disease/Condition
• Table 8-7: Clinical Trials in Rishon Lezion, Israel by Disease/Condition
• Figure 8-10: Clinical Trials in Rishon Lezion - Distribution by Disease/Condition
• Figure 8-11: Clinical Trials in Rishon Lezion, Israel by Disease/Condition
• Table 8-8: Comparison of Clinical Trail Market Drivers and Inhibitors -Israel
• Table 8-9: Clinical Trial Market in Israel 2006-2012
• Figure 8-12: Clinical Trial Market in Israel 2006-2012
• Figure 8-13: Clinical Trial Market - Israel vs. World Markets, 2006